Pharma Marketing Network

NOVEMBER 15, 2024

Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influencers and Patient Stories 5 Analyze and Optimize Regularly 1. Are you trying to engage healthcare professionals (HCPs), patients, or caregivers?

Media 52

Media Pharma Marketing Medical 52

PM360

OCTOBER 8, 2024

First of its kind, in-office, digital hub enhances provider efficiency and care team collaboration Cincinnati, Ohio – October 7, 2024 – PatientPoint® a leading digital health company, today showcased the transformation of its healthcare professional solution with the launch of an interactive, in-office digital hub.

Healthcare Provider 52

Healthcare Provider Pharma reps Pharma Rep Physicians 52

PM360

OCTOBER 25, 2023

According to a report by McKinsey & Company, the medical affairs function is on track to rise in importance, becoming the third strategic pillar alongside the research and development (R&D) and commercial functions by 2025. This lack of understanding may lead to resistance or wariness of new technology. Regulatory concerns.

Management 105

Management Medical Pharma Pharmaceutical 105

pharmaphorum

SEPTEMBER 21, 2022

The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only biologic that can be used in all patients, and not restricted to those with specific forms of the disease. billion or more.

Sales 108

Sales Patients Biopharma Medicine 108

pharmaphorum

OCTOBER 26, 2022

The drug was highlighted at Boehringer’s R&D update earlier this year as one of the most promising candidates among 15 new medicines it plans to bring to market by 2025, fuelled by a €25 billion R&D spend. The programme will include two trials – FIBRONEER IPF and FIBRONEER-ILD – which will recruit patients across 40 countries.

Recruitment 93

Recruitment Prospecting Marketing Patients 93

Pharmaceutical Technology

JUNE 8, 2023

Mendus has entered an alliance with NorthX Biologics to co-establish a cell therapy manufacturing unit for its lead asset, vididencel, in Sweden. The cell therapy facility will be used for the large-scale production of vididencel, Mendus’s lead programme. All operations will take place there until the second quarter of 2025.

Manufacturing 52

Manufacturing Leads Patients Medicine 52

European Pharmaceutical Review

NOVEMBER 23, 2023

For example, CPI asserted that lead times for clinical trial materials are hindering new therapies being developed. The Oligonucleotide Manufacturing Innovation Centre of Excellence will also facilitate “a highly skilled workforce” to be trained and development to accelerate access of these medicines to patients, CPI noted.

Manufacturing 104

Manufacturing Medicine Government Pharmaceutical 104

Pharmaceutical Technology

APRIL 17, 2023

The proposed merger is expected to realise at least $50m of net transaction cash proceeds, set to be used to finance the merged entity’s business as well as Phase II trials and operations through the second quarter of 2025. The merger is scheduled to be completed by the third quarter of 2023.

Patients 98

Patients Leads Pharmaceutical Marketing 98

pharmaphorum

JANUARY 9, 2023

Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50

Pharma 85

Pharma Biopharma Management Medicine 85

Pharmaceutical Technology

DECEMBER 21, 2022

The vaccine manufacturing facility will also offer National Health Service (NHS) patients access to the company’s Covid-19 vaccines that can provide protection against various variants. Planned to be operational by 2025, the construction of the facility is anticipated to begin early next year.

Government 140

Government Manufacturing Pharmaceutical Marketing 140

pharmaphorum

SEPTEMBER 14, 2022

SparingVision’s lead candidates are both targeting inherited retinal diseases (IRDs), a group which already has a gene therapy on the market in Novartis’ Luxturna (voretigene neparvovec), which was approved by the FDA in 2017 for biallelic RPE65 mutation-associated retinal dystrophy, a group which includes a small group of RP patients.

Safety 52

Safety Leads Patients FDA 52

European Pharmaceutical Review

MARCH 14, 2024

This month, new data from Novo Nordisk has revealed that semaglutide could become the first GLP-1 treatment option for patients with type 2 diabetes and chronic kidney disease (CKD). This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function.

Food and Drug Administration 98

Food and Drug Administration Leads Patients Side effects 98

European Pharmaceutical Review

MARCH 14, 2024

This month, new data from Novo Nordisk has revealed that semaglutide could become the first GLP-1 treatment option for patients with type 2 diabetes and chronic kidney disease (CKD). This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function.

Food and Drug Administration 98

Food and Drug Administration Leads Patients Side effects 98

Pharmaceutical Technology

SEPTEMBER 5, 2022

Until 2025, we have strong growth ahead of us, but we also believe we can continue to grow very strongly post-2025 and it’s all about innovation in the pipeline.”. On 23 August, at a Reuters Newsmakers online forum, Soriot announced his interest in increasing AstraZeneca’s portfolio of bolt-on acquisitions leading up to 2025.

FDA 114

FDA Pharmaceutical Biopharma Pharma 114

Pharmaceutical Technology

JANUARY 19, 2023

While allogeneic hematopoietic stem cell transplants (HSCT) provide long-term benefit to a subset of AML patients, other cell therapy modalities such as natural killer (NK) cells or chimeric antigen receptor (CAR)-T cells have failed to show conclusive benefit in late-stage clinical trials.

Marketing 52

Marketing FDA Sales Management 52

European Pharmaceutical Review

AUGUST 1, 2022

The goal is to “ensure all patient groups are reflective of the real-world population and aligned with the epidemiology of the disease studies,” a statement said. Therefore, it is essential that we broaden the scope of medical trials and research,” commented Tinamarie Duff, DAWN Global People & Business Resource Group Lead.

Food and Drug Administration 122

Food and Drug Administration Medical Medicine Engineering 122

Pharmaceutical Technology

AUGUST 11, 2022

The proceeds from the business combination will be utilised to advance the pipeline of Disc to clinical trials and offer funding into 2025. Disc focuses on discovering and developing new therapies for patients with serious haematologic ailments.

Medicine 59

Medicine Transportation Patients Healthcare 59

Pharmaceutical Technology

MAY 2, 2023

Marker Therapeutics CEO Juan Vera stated: “Marker’s management and impartial members of the board worked with John Wilson and CellReady to develop a very creative and non-dilutive plan that provides Marker with the financial runway to pursue its clinical priorities through the end of 2025. “At

Manufacturing 52

Manufacturing Leads Management Pharmaceutical 52

PM360

SEPTEMBER 21, 2023

This article covers some of the reasons these drugs were chosen, how the process for price negotiation will occur, and the impact for the industry and for patients. Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

European Pharmaceutical Review

JUNE 12, 2024

The study included 92 adult patients with confirmed CDI. After treatment, patients were followed up at intervals of 72 hours, three weeks, eight weeks, three months and six months. Safety and quality of life of the patients participating in the study were also assessed. percent of those treated with fidaxomicin. Intern Med J.

Safety 111

Safety Side effects Patients Healthcare 111

Pharmaceutical Technology

NOVEMBER 1, 2022

Israel, another leading adopter, has a thriving EHR technology industry that is adapting to the country’s widespread use of Big Data from its country’s healthcare systems. This includes issues related to drug shortages and research into new therapeutics, which will be addressed in the EMA’s strategy for 2025. “We

Electronics 111

Electronics Prescription Healthcare Healthcare 111

Pharmaceutical Technology

JANUARY 8, 2023

Today, approximately 384 million people around the globe have COPD and it is the third leading cause of death worldwide, the Global Initiative for Chronic Obstructive Lung Disease reports. While options like bronchodilator inhalers are available for COPD patients, these have limitations. Biologics: From asthma to COPD?

Patients 119

Patients FDA Pharmaceutical Pharma 119

pharmaphorum

OCTOBER 13, 2022

It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. However, there is a problem facing the treatment of osteoporosis, and it is the lack of research into new therapies, leading to a limited pipeline of new treatments coming through.

Marketing 88

Marketing Healthcare Healthcare Leads 88

PM360

JULY 13, 2023

billion by 2025, growing at a compound annual growth rate of 6.7%. billion by 2025, growing at a compound annual growth rate of 6.7%. Solving this will require reassembling these solutions to put the patient at the center of the healthcare experience. The global healthcare IT market was valued at $280.3

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Pharmaceutical Technology

MAY 5, 2023

The facility will be situated with DiNAMIQS’ existing operations at Bio-Technopark in Zurich-Schlieren, Switzerland, and is anticipated to become operational in 2025. Siegfried will leverage DiNAMIQS’ capabilities to commercial scale by constructing a facility that complies with good manufacturing practice standards.

Leads 52

Leads Manufacturing Management Pharmaceutical 52

Penrod

JUNE 6, 2024

Health Cloud was a version of Salesforce CRM tailored to healthcare providers, insurance companies, and other organizations’ unique needs with patient-focused business models. To some extent, this patient model fits the requirements of med dev and pharma pretty well, but it wasn’t one-size-fits-all.

CRM 52

CRM Food and Drug Administration Healthcare Provider Management 52

LEVO Health

MAY 7, 2024

Additionally, this marketing avenue helps practices and healthcare providers create meaningful patient relationships, foster loyalty, and drive business growth. This helps healthcare organizations break through the traditional barriers of trust and establish a more relatable presence in the eyes of potential patients.

Healthcare 52

Healthcare Healthcare Marketing Healthcare Provider 52

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share. And he has a unique view of how data and health combine.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. A recent report from GlobalData predicted that pharma spending on AI drug discovery would hit $3 billion in 2025.

Medicine 78

Medicine Pharma Engineering Sales 78

Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52

Retail Healthcare Healthcare Physicians 52

LEVO Health

NOVEMBER 30, 2021

To fully optimize the benefits of social media , it is crucial to stay on top of the latest trends to reach a greater number of patients. By 2025, social commerce sales are expected to reach 79.6 Patients can now effectively learn about your brand from the comfort of their own homes. 2022 Social Media Marketing Trends.

Media 52

Media Healthcare Healthcare Marketing 52

Rep-Lite

JULY 27, 2023

In today’s fast-evolving world, the medical sales industry stands at the forefront of innovation, with medical devices playing a pivotal role in patient care and treatment. billion by 2025. Navigating Regulatory Changes and Compliance The medical device industry operates under strict regulations to ensure patient safety.

Sales 52

Sales Medical Medical sales Sales Strategy 52

pharmaphorum

SEPTEMBER 22, 2022

The “US-first” mindset will lead to higher proportions of American patients in its clinical trials and investment in “capability and talent” in the US, where it aims to become a top-five player by 2027 – a big advance on its current 10th place. .”

Management 52

Management Sales Patients Marketing 52

Eversana Intouch

SEPTEMBER 27, 2024

Here are a few of the things we learned and some associated implications heading into 2025. Both manufacturers and marketers need to understand how HCPs make these decisions and which patients are likely to benefit from one type of treatment over another. EVERSANA was there with teams from across the U.S.

Patients 59

Patients Medical Healthcare Healthcare 59

pharmaphorum

OCTOBER 19, 2022

It can simultaneously bind two non-overlapping epitopes of HER2 (known as ‘biparatopic binding’) and result in such novel mechanisms of action as dual HER2 signal blockade and removal of HER2 protein from the cell surface – this potent effector function leading to encouraging anti-tumour activity in patients.

Sales 40

Sales Pharmaceutical FDA Patients 40

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Prescription refills can now be placed with a simple click on a patient portal. Reconsider the Role of Packaging.

Retail 97

Retail Marketing Healthcare Healthcare 97

Pharmaceutical Technology

SEPTEMBER 22, 2022

“It's very difficult in the current environment, given the pressure on the health economies to make sure that you're successful everywhere, but we really have a strong belief in the value that we're bringing, health economics-wise, patient-wise, to the overall system to tackle cardiovascular disease.”. Cardiovascular disease landscape.

Pharmaceutical 52

Pharmaceutical Marketing FDA Leads 52